SCHEMBL2994316

SCHEMBL2994316

CC(C)(CCl)C(=O)NCCCCl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.43
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PTGS1 P23219 1/20 0.38
KCNH2 Q12809 1/20 0.38
HTT P42858 2/20 0.38
LMNA P02545 1/20 0.38
EPHX1 P07099 1/20 0.37
CA12 O43570 1/20 0.35
CA2 P00918 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7031804 0.87 HTT (0.40) FAAHALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL21666572 0.83 POLB (0.50) FAAHALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL7036071 0.81 CNR1 (0.44) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL21666562 0.79 FAAH (0.43) FAAHALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL11592861 0.76 LMNA (0.49) FAAHALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL2431800 0.74 ALDH1A1 (0.74) FAAHALDH1A1SMN1; SMN2POLBMEN1
SCHEMBL6850579 0.73
SCHEMBL21976540 0.72 PTGS1 (0.47) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL9476287 0.72 CTH (0.40) ALDH1A1MEN1KMT2AHTTLMNA
SCHEMBL6852859 0.72 HTT (0.44) ALDH1A1POLBMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100184770-A1 COMPOUNDS GLAXO GROUP LIMITED 2010-07-22 US disclosed
EP-2091538-B1 4-BENZYL-1(2H)-PHTHALAZINONES AS H1 RECEPTOR ANTAGONISTS GLAXO GROUP LTD (GB) 2010-03-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100184770-A1 COMPOUNDS CMA1, TSLP, IL5 FAAH 1168/4885ALDH1A1 516/4885SMN1; SMN2 4658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.